Article
The CYP2C19 enzyme polymorphism.
Pharmacology - 1 Sept 2000
Wedlund P J
Abstract excerpt
The genetic test is gradually replacing probe drugs as the primary tool for screening populations for the CYP2C19 polymorphism. A full appreciation for the clinical and toxicological relevance of this genetic variation is presently limited. Further research is needed in several areas. The development and use of 3-D models of the CYP2C19 enzyme to automate and increase the rate at which CYP2C19 substrates are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
